Abstract |
Studies on the chemotherapeutic potential of methyl-CCNU on experimental leukemias were undertaken. A number of murine transplantable in vivo lines (chemical carcinogen-induced T and B leukemias; radiation- and viral-induced T leukemias of C57BL/6, C3H/eb and SJL/J origin; radiation-induced myeloid leukemias and spontaneous reticulum cell neoplasms of SJL/J mine) were used in these studies. The optimal dose of methyl-CCNU and optimal timing of administration were extensively investigated on two sample lines of T cell leukemias of C57BL/6 mice. Leukemic cell eradication could be achieved in almost all of the different leukemias treated, irrespective of whether induction was brought about by chemical or physical means or due to a viral leukemogenic agent. Studies undertaken to elucidate the effect of methyl-CCNU on the establishment of preleukemic cells following induction of leukemia by the radiation leukemia virus (RadLV) or by total body irradiation, indicated the oncostatic effect of methyl-CCNU on early preleukemic cells.
|
Authors | A Peled, K Perk, N Haran-Ghera, M A Chirigos |
Journal | Leukemia research
(Leuk Res)
Vol. 6
Issue 1
Pg. 89-95
( 1982)
ISSN: 0145-2126 [Print] England |
PMID | 6803071
(Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Nitrosourea Compounds
- Semustine
- 9,10-Dimethyl-1,2-benzanthracene
|
Topics |
- 9,10-Dimethyl-1,2-benzanthracene
- Animals
- Blood Cell Count
- Body Weight
- Drug Administration Schedule
- Drug Evaluation, Preclinical
- Female
- Hematocrit
- Leukemia, Experimental
(drug therapy, etiology)
- Leukemia, Radiation-Induced
(drug therapy)
- Mice
- Mice, Inbred Strains
- Nitrosourea Compounds
(therapeutic use)
- Precancerous Conditions
(drug therapy, etiology)
- Retroviridae
- Semustine
(therapeutic use)
|